ArticleBulletin of the World Health Organization2012
Use of evidence to support healthy public policy: a policy effectiveness-feasibility loop.
Article in Bulletin of the World Health Organization, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The future of public health policymaking after COVID-19: a qualitative systematic review of lessons from Health in All Policies.Open research Europe · 2021Pooled it
- Enhancing public health through multi-stakeholder collaboration in Africa.Annals of medicine and surgery (2012) · 2024Article
- Adapting waterpipe-specific pictorial health warning labels to the Tunisian context using a mixed method approach.PloS one · 2023Article
- Why is health improvement policy so difficult to secure?Open research Europe · 2022Article
- The legal feasibility of adopting a sugar-sweetened beverage tax in seven sub-Saharan African countries.Global health action · 2021Article
- Management of diabetics. Comparative study of two contrasting health structures.La Tunisie medicale · 2021Article
- Ottawa charter framework as a guide for type 2 diabetes prevention and control in Iran.Journal of diabetes and metabolic disorders · 2019Article
- Dementia Primary Prevention Policies and Strategies and Their Local Implementation: A Scoping Review Using England as a Case Study.Journal of Alzheimer's disease : JAD · 2019Article
- National action plan for non-communicable diseases prevention and control in Iran; a response to emerging epidemic.Journal of diabetes and metabolic disorders · 2017Review
- The role of the Sheffield model on the minimum unit pricing of alcohol debate: the importance of a rhetorical perspective.Evidence & policy : a journal of research, debate and practice · 2016Article
- A survey of knowledge-to-action pathways of aging policies and programs in the Arab region: the role of institutional arrangements.Implementation science : IS · 2015Article
- Simple calculator to estimate the medical cost of diabetes in sub-Saharan Africa.World journal of diabetes · 2015Article
- MedCHAMPS: Mediterranean studies of cardiovascular disease and hyperglycaemia: analytical modelling of population socio-economic transitions.International journal of public health · 2015Article
- Health policy analysis for prevention and control of cardiovascular diseases and diabetes mellitus in Turkey.International journal of public health · 2015Article
- Priority setting for the prevention and control of cardiovascular diseases: multi-criteria decision analysis in four eastern Mediterranean countries.International journal of public health · 2015Article
- Living with diabetes and hypertension in Tunisia: popular perspectives on biomedical treatment.International journal of public health · 2015Article
- Health system challenges for the management of cardiovascular disease and diabetes: an empirical qualitative study from Syria.International journal of public health · 2015Article
- Cardiovascular risk factor trends in the Eastern Mediterranean region: evidence from four countries is alarming.International journal of public health · 2015Article
- Comparison of type 2 diabetes prevalence estimates in Saudi Arabia from a validated Markov model against the International Diabetes Federation and other modelling studies.Diabetes research and clinical practice · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Public policy plays a key role in improving population health and in the control of diseases, including non-communicable diseases. However, an evidence-based approach to formulating healthy public policy has been difficult to implement, partly on account of barriers that hinder integrated work between researchers and policy-makers. This paper describes a "policy effectiveness-feasibility loop" (PEFL) that brings together epidemiological modelling, local situation analysis and option appraisal to foster collaboration between researchers and policy-makers. Epidemiological modelling explores the determinants of trends in disease and the potential health benefits of modifying them. Situation analysis investigates the current conceptualization of policy, the level of policy awareness and commitment among key stakeholders, and what actually happens in practice, thereby helping to identify policy gaps. Option appraisal integrates epidemiological modelling and situation analysis to investigate the feasibility, costs and likely health benefits of various policy options. The authors illustrate how PEFL was used in a project to inform public policy for the prevention of cardiovascular diseases and diabetes in four parts of the eastern Mediterranean. They conclude that PEFL may offer a useful framework for researchers and policy-makers to successfully work together to generate evidence-based policy, and they encourage further evaluation of this approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.